Vinayak Nagaraja1, Guy D Eslick1, Michael R Cox1. 1. The Whiteley-Martin Research Centre, Discipline of Surgery, The Sydney Medical School Nepean, Penrith, New South Wales, Australia.
Abstract
BACKGROUND: Sentinel lymph nodes (SLNs) have been used to predict regional lymph node metastasis in patients with melanoma and breast cancer. However, the validity of the SLN hypothesis is still controversial for oesophageal cancer. We performed this meta-analysis to evaluate the feasibility and accuracy of radio-guided SLN mapping for oesophageal cancer. METHODS: A systematic search was conducted using MEDLINE, PubMed, EMBASE, Current Contents Connect, Cochrane library, Google scholar, Science Direct, and Web of Science. Original data was abstracted from each study and used to calculate a pooled event rates and 95% confidence interval (95% CI). RESULTS: The search identified 23 relevant articles. The overall detection rate was 0.93 (95% CI: 0.894-0.950), sensitivity 0.87 (95% CI: 0.811-0.908), negative predictive value 0.77 (95% CI: 0.568-0.890) and the accuracy was 0.88 (95% CI: 0.817-0.921). In the adenocarcinoma cohort, detection rate was 0.98 (95% CI: 0.923-0.992), sensitivity 0.84 (95% CI: 0.743-0.911) and the accuracy was 0.87(95% CI: 0.796-0.913). In the squamous cell carcinoma group, detection rate was 0.89 (95% CI: 00.792-0.943), sensitivity 0.91 (95% CI: 0.754-0.972) and the accuracy was 0.84 (95% CI: 0.732-0.914). CONCLUSIONS: It is possible to identify and obtain a SLN before neoadjuvant therapy in oesophageal cancer. However, further work is needed to optimize radiocolloid type, refine the technique and develop a quick and accurate way to determine SLN status intraoperatively. This technique has to be further evaluated before it can be applied widely.
BACKGROUND: Sentinel lymph nodes (SLNs) have been used to predict regional lymph node metastasis in patients with melanoma and breast cancer. However, the validity of the SLN hypothesis is still controversial for oesophageal cancer. We performed this meta-analysis to evaluate the feasibility and accuracy of radio-guided SLN mapping for oesophageal cancer. METHODS: A systematic search was conducted using MEDLINE, PubMed, EMBASE, Current Contents Connect, Cochrane library, Google scholar, Science Direct, and Web of Science. Original data was abstracted from each study and used to calculate a pooled event rates and 95% confidence interval (95% CI). RESULTS: The search identified 23 relevant articles. The overall detection rate was 0.93 (95% CI: 0.894-0.950), sensitivity 0.87 (95% CI: 0.811-0.908), negative predictive value 0.77 (95% CI: 0.568-0.890) and the accuracy was 0.88 (95% CI: 0.817-0.921). In the adenocarcinoma cohort, detection rate was 0.98 (95% CI: 0.923-0.992), sensitivity 0.84 (95% CI: 0.743-0.911) and the accuracy was 0.87(95% CI: 0.796-0.913). In the squamous cell carcinoma group, detection rate was 0.89 (95% CI: 00.792-0.943), sensitivity 0.91 (95% CI: 0.754-0.972) and the accuracy was 0.84 (95% CI: 0.732-0.914). CONCLUSIONS: It is possible to identify and obtain a SLN before neoadjuvant therapy in oesophageal cancer. However, further work is needed to optimize radiocolloid type, refine the technique and develop a quick and accurate way to determine SLN status intraoperatively. This technique has to be further evaluated before it can be applied widely.
Entities:
Keywords:
Sentinel lymph nodes (SLNs); esophageal adenocarcinoma; esophageal cancer
Authors: T Nomura; M Onda; M Miyashita; H Makino; H Maruyama; S Nagasawa; R Futami; K Yamashita; K Takubo; K Sasajima Journal: J Nippon Med Sch Date: 2001-10 Impact factor: 0.920
Authors: T Matsubara; M Ueda; S Kaisaki; J Kuroda; C Uchida; N Kokudo; T Takahashi; T Nakajima; A Yanagisawa Journal: Cancer Date: 2000-11-01 Impact factor: 6.860
Authors: E Orsenigo; V Tomajer; S Di Palo; L Albarello; C Doglioni; E Masci; E Viale; C Staudacher Journal: Surg Endosc Date: 2007-05-05 Impact factor: 4.584
Authors: Mohammad A Bhat; Zahoor A Naikoo; Tufail A Dass; Riyaz A Lone; Abdul M Dar Journal: Saudi J Gastroenterol Date: 2010 Jul-Sep Impact factor: 2.485
Authors: Anouk Overwater; Bas L A M Weusten; Jelle P Ruurda; Richard van Hillegersberg; Roel J Bennink; Bart de Keizer; Sybren L Meijer; Lodewijk A A Brosens; Roos E Pouw; Jacques J G H M Bergman; Mark I van Berge Henegouwen; Suzanne S Gisbertz Journal: Surg Endosc Date: 2021-05-27 Impact factor: 4.584